 - Patients affected by Crohns Disease, particularly involving sigmoid colon and rectum diagnosed on the base of clinic, endoscopic, and histologic criteria in clinical remission CDAI 150 from at least three months and in stable therapy without therapeutic modifications in the three previous months with mesalazine A, immunomodulators andor biologics. 